Omsana DIU (Olmesartan Medoxomil/Hydrochlorothiazide)20/12.5mg tablets

528

15 People watching this product now!

Payment Methods:

Description

Omsana-DIU (Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg) Tablets

Effective Combination Therapy for High Blood Pressure Control

Omsana-DIU combines Olmesartan Medoxomil (an angiotensin II receptor blocker – ARB) and Hydrochlorothiazide (a diuretic) to provide enhanced blood pressure reduction. This combination relaxes blood vessels and removes excess fluid from the body, helping to maintain healthy blood pressure levels and reduce the risk of heart disease, stroke, and kidney complications.

Key Benefits

Effectively Lowers High Blood Pressure – Dual action for better BP control.
Reduces Fluid Retention & Swelling – Helps prevent excess water buildup.
Protects Heart & Kidney Health – Reduces strain on vital organs.
Provides 24-Hour Blood Pressure Control – Convenient once-daily dosage.
Suitable for Long-Term Use – Well-tolerated with fewer side effects.

How to Use

  • Take one tablet daily, or as prescribed by your doctor.
  • Swallow whole with water; do not crush or chew.
  • Can be taken with or without food.
  • Maintain a low-sodium diet and regular exercise for best results.

Important Information

  • Stay hydrated to prevent dehydration from increased urination.
  • May cause dizziness; avoid driving if you feel lightheaded.
  • Monitor kidney function, blood pressure, and potassium levels regularly.
  • Not suitable during pregnancy or for individuals with severe kidney/liver disease.
  • Consult a doctor before use if taking other medications for blood pressure or heart conditions.

Omsana-DIU is a highly effective treatment for hypertension, helping patients maintain stable blood pressure, reduce fluid retention, and support overall cardiovascular health.

Customer Reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Omsana DIU (Olmesartan Medoxomil/Hydrochlorothiazide)20/12.5mg tablets”

Your email address will not be published. Required fields are marked *

1 2 3 4 5
1 2 3 4 5
1 2 3 4 5